Veracyte Net Income From Continuing Ops from 2010 to 2026
| VCYT Stock | USD 38.08 0.66 1.70% |
Net Income From Continuing Ops | First Reported 2011-12-31 | Previous Quarter -980 K | Current Value 19.1 M | Quarterly Volatility 9.7 M |
Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.3 M, Interest Expense of 1.7 K or Selling General Administrative of 215.3 M, as well as many indicators such as Price To Sales Ratio of 13.72, Dividend Yield of 0.0 or PTB Ratio of 2.81. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
Veracyte | Net Income From Continuing Ops | Build AI portfolio with Veracyte Stock |
The evolution of Net Income From Continuing Ops for Veracyte provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Veracyte compares to historical norms and industry peers.
Latest Veracyte's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Veracyte over the last few years. It is Veracyte's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veracyte's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Veracyte Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (22,311,745) | |
| Geometric Mean | 29,755,122 | |
| Coefficient Of Variation | (121.45) | |
| Mean Deviation | 18,551,919 | |
| Median | (25,580,000) | |
| Standard Deviation | 27,097,850 | |
| Sample Variance | 734.3T | |
| Range | 104.7M | |
| R-Value | 0.39 | |
| Mean Square Error | 666.7T | |
| R-Squared | 0.15 | |
| Significance | 0.13 | |
| Slope | 2,070,083 | |
| Total Sum of Squares | 11748.7T |
Veracyte Net Income From Continuing Ops History
About Veracyte Financial Statements
Veracyte shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 27.8 M | 29.1 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.